STUDY: PrEP is Still Pretty Effective When Taken Less Than Daily—But is it Enough?

There may be some catches, but a new study on PrEP suggests that anti-HIV medication can still effectively fight infections even if they aren't taken on a daily basis.

"Researchers announced that that the shortened dosage reduced the risk of HIV in gay and bi men by an average of over 86 percent. But don’t think that means it’s an on-demand drug, or a before and after pill, as was previously reported in the media last year.

Currently PrEP is only approved for daily use, and if taken as studied in the IPERGAY and PROUD trials some experts warn users could be putting themselves at risk for contracting HIV."